In concert with this, our findings showed that suppressing the expression of AurA in HPV16-positive cervical cancer cells, either using potent AurA inhibitors, like MK5108 and Alisertib, or via siRNA targeting AurA specifically, can efficiently suppress the oncogenic potential, particularly the invasive ability of the HPV-positive cells. This evidence concerns the gene AURKA and cervical carcinoma.